Data from prostate cancer suggest that SOCS2-AS1 lncRNA is involved in the disease by promoting androgen signaling due to the modulation of the epigenetic control for androgen receptors target genes [43]. The gene discussed is SOCS2; the disease is prostate carcinoma.